New York (dpa-Afx broker)-The US bank JPmorgan has reduced the price target for Evonik from 21.50 to 20 euros, but left the classification to “Overweight”. Analyst Chetan Udeshi cut his estimates for the chemical group for the second time this month. In his comment on Friday, he reacted to the unusual forecasting even more than feared. Udeshi, however, remains in view of the favorable assessment when it comes to its recommendation of the shares./AG/ZB
Publication of the original study: 26.09.2025 / 00:10 / BST
First disclosure of the original study: 26.09.2025 / 00:15 / BST
Selected leverage products on Evonik
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Evonik
The lever must be between 2 and 20
Advertising